C3i names Song business development executive in Asia

Monday, July 16, 2012 10:57 AM

C3i, which provides service desk support and business process outsourcing (BPO) services for the life sciences industry, has appointed Jonathan Song business development executive in Asia.

C3i recently opened an operations center in Dalian, China to address the IT support needs of pharmaceutical companies doing business in the main Asian markets. Song will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organizations in Asia.

Song has 20 years of pharmaceutical and healthcare experience in China and the U.S., both in industry and agency, including positions at Merck and Sinopharm.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs